科越医药（上海）有限公司

公司简介

科越医药是一家基于尖端补体免疫学的生物技术创业型公司。于2017年完成了数千万美元的A轮融资，随后于中美两地相继建立了研发实验室和运营团队。科越医药的管理团队由多名华人科学家以及来自国际医药巨头的高级人才组成，具有先进医药研发经验。凭借独特的技术平台优势，致力于成为全球补体类创新药（First-in-class or Best-in-class）的领跑者，特别是针对尚无治疗手段的疾病的新药研发。Kira Pharmaceuticals is a biotech startup based on cutting-edge complement immunological sciences, with research labs and operations both in China and US, led by pharmaceutical/biotech veterans. The company has completed a tens of million Series A financing in 2017 with industry leading VC/PE funds. With the unique strength and advantages, Kira strives to become a global leader in innovative drug research & development to address highly unmet medical needs for patients in China and the rest of the world.